Research location
Mesa
Arizona, United States
Research activity in Mesa
Arizona, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 372 trials and 421 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Mesa
372 linked trials · page 1 of 8A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 ObesityNCT07794579 · 2026-08-26 · 1 site observation
RECRUITING
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or OverweightNCT07784270 · 2026-08-20 · 1 site observation
RECRUITING
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes MellitusNCT07784725 · 2026-08-19 · 1 site observation
RECRUITING
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes MellitusNCT07662213 · 2026-07-06 · 1 site observation
RECRUITING
Study to Evaluate HM15275 in Subjects With Type 2 Diabetes MellitusNCT07527650 · 2026-05-18 · 1 site observation
RECRUITING
A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical PracticeNCT07556159 · 2026-04-01 · 1 site observation
RECRUITING
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or OverweightNCT07353931 · 2026-02-09 · 2 site observations
RECRUITING
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung CancerNCT07222566 · 2026-01-06 · 2 site observations
RECRUITING
The WiSE®-UP Study (The WiSE System Utilization & Performance Study)NCT07098858 · 2025-11-03 · 1 site observation
RECRUITING
CCM OPEN HF RegistryNCT07112924 · 2025-11-01 · 1 site observation
RECRUITING
A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or OverweightNCT07202884 · 2025-09-30 · 1 site observation
RECRUITING
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.NCT07028853 · 2025-09-28 · 2 site observations
RECRUITING
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular DiseaseNCT07181109 · 2025-09-22 · 1 site observation
RECRUITING
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.NCT07062965 · 2025-08-05 · 2 site observations
RECRUITING
Balance4Mobility: Effects of Walkasins Use in Individuals With Peripheral Neuropathy and Balance ProblemsNCT06959277 · 2025-06-17 · 1 site observation
RECRUITING
Efficacy of Surgical Systems in Combination With Phacoemulsification: a Retrospective AnalysisNCT06953349 · 2025-03-31 · 1 site observation
RECRUITING
DSLT Performance in Treatment-naïve Patients With Newly Diagnosed Open Angle GlaucomaNCT06933836 · 2025-03-31 · 1 site observation
RECRUITING
Ultra-High Frequency - Electrocardiogram (UHF-ECG) for the Diagnosis of Ventricular Electrical Dyssynchrony (VED)NCT06641362 · 2025-03-18 · 1 site observation
RECRUITING
The CDK4/6 Inhibitor Dosing Knowledge (CDK) StudyNCT06377852 · 2024-10-29 · 2 site observations
RECRUITING
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.NCT06629779 · 2024-10-22 · 2 site observations
RECRUITING
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary DiseaseNCT06283966 · 2024-02-21 · 2 site observations
RECRUITING
Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot UlcersNCT05758545 · 2023-06-19 · 1 site observation
RECRUITING
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With OsteosarcomaNCT05235165 · 2022-04-01 · 1 site observation
RECRUITING
Assessment of CCM in HF With Higher Ejection FractionNCT05064709 · 2022-02-03 · 3 site observations
RECRUITING
Efficacy and Safety of Ribupatide (KAI-9531) Administered Once Weekly in Participants Living With Obesity Who Do Not Have DiabetesNCT07458269 · 2026-03-04 · 1 site observation
ACTIVE_NOT_RECRUITING
A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)NCT07176390 · 2025-10-08 · 1 site observation
ACTIVE_NOT_RECRUITING
Study to Explore the Safety and Efficacy of NT-0796 as an Adjunct to Semaglutide in Participants With Obesity (RESOLVE-2)NCT07220629 · 2025-10-02 · 1 site observation
COMPLETED
Evaluate the Efficacy and Safety of NT-0796 in Participants With Obesity With or Without Type 2 Diabetes MellitusNCT07055516 · 2025-05-08 · 1 site observation
COMPLETED
A Study of LY3541860 in Adult Participants With Moderately to Severely Active Rheumatoid ArthritisNCT06859294 · 2025-03-19 · 1 site observation
TERMINATED
Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are OverweightNCT06858878 · 2025-03-17 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)NCT06864026 · 2025-03-06 · 1 site observation
ACTIVE_NOT_RECRUITING
WATER IV Prostate CancerNCT06651632 · 2025-02-03 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Evaluate the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With Active, Difficult to Treat Rheumatoid ArthritisNCT06754462 · 2025-01-10 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic DiseaseNCT06760637 · 2025-01-06 · 2 site observations
ACTIVE_NOT_RECRUITING
Non-healing Diabetic Foot Ulcers Treated With Standard Care With or Without BR-AMNCT06565156 · 2024-10-28 · 1 site observation
COMPLETED
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)NCT06653153 · 2024-10-24 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).NCT06551324 · 2024-10-21 · 2 site observations
ACTIVE_NOT_RECRUITING
Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or OverweightNCT06588296 · 2024-09-24 · 1 site observation
COMPLETED
A Dose Range-Finding Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD8630 in Adults With Uncontrolled Asthma at Risk of ExacerbationsNCT06529419 · 2024-08-30 · 1 site observation
COMPLETED
A Study of Enicepatide (CT-388) in Participants With Obesity or Overweight With at Least One Weight-Related ComorbidityNCT06525935 · 2024-08-16 · 1 site observation
COMPLETED
Efficacy and Safety of Oral Azelaprag Plus Once Weekly Tirzepatide Compared with Tirzepatide Alone in Participants with Obesity Aged 55 Years and OverNCT06515418 · 2024-06-27 · 1 site observation
TERMINATED
A Dose Finding Study of Debio 4228 in Participants With Advanced Prostate CancerNCT06395753 · 2024-05-23 · 1 site observation
COMPLETED
A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjogren's SyndromeNCT06312020 · 2024-05-09 · 1 site observation
TERMINATED
A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Help People With Excess Body Weight Lose WeightNCT06326060 · 2024-03-18 · 1 site observation
COMPLETED
SkinTE® for the Treatment of Wagner 1 Diabetic Foot Ulcers (COVER DFUS II)NCT06140303 · 2024-02-22 · 1 site observation
ACTIVE_NOT_RECRUITING
Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)NCT06098079 · 2024-01-03 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2NCT06003231 · 2023-11-14 · 2 site observations
ACTIVE_NOT_RECRUITING
A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 DiabetesNCT05936151 · 2023-07-20 · 1 site observation
COMPLETED
Assessment of Combined CCM and ICD Device in HFrEFNCT05855135 · 2023-05-17 · 2 site observations
ACTIVE_NOT_RECRUITING
A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular RiskNCT05803421 · 2023-04-03 · 1 site observation
COMPLETED
How to interpret this record
CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.